171 related articles for article (PubMed ID: 35018826)
21. Murine pluripotent stem cells that escape differentiation inside teratomas maintain pluripotency.
Pei Y; Yue L; Zhang W; Xiang J; Ma Z; Han J
PeerJ; 2018; 6():e4177. PubMed ID: 29312817
[TBL] [Abstract][Full Text] [Related]
22. The tumourigenicity of iPS cells and their differentiated derivates.
Liu Z; Tang Y; Lü S; Zhou J; Du Z; Duan C; Li Z; Wang C
J Cell Mol Med; 2013 Jun; 17(6):782-91. PubMed ID: 23711115
[TBL] [Abstract][Full Text] [Related]
23. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
[TBL] [Abstract][Full Text] [Related]
24. Characterization of immature ovarian teratomas through single-cell transcriptome.
Cao M; Deng Y; Deng Y; Wu J; Yang C; Wang Z; Hou Q; Fu H; Ren Z; Xia X; Li Y; Wang W; Xu H; Liao X; Shu Y
Front Immunol; 2023; 14():1131814. PubMed ID: 36936909
[TBL] [Abstract][Full Text] [Related]
25. Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control.
Kim MJ; Lee EY; You YH; Yang HK; Yoon KH; Kim JW
Stem Cell Res; 2020 Oct; 48():101958. PubMed ID: 32882526
[TBL] [Abstract][Full Text] [Related]
26. Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.
Okur FV; Cevher İ; Özdemir C; Kocaefe Ç; Çetinkaya DU
Stem Cell Res Ther; 2019 Jul; 10(1):211. PubMed ID: 31315669
[TBL] [Abstract][Full Text] [Related]
27. Caffeic acid selectively eliminates teratogenic human-induced pluripotent stem cells via apoptotic cell death.
Kim A; Lee SY; Chung SK
Phytomedicine; 2022 Jul; 102():154144. PubMed ID: 35537368
[TBL] [Abstract][Full Text] [Related]
28. Ethanol extract of Magnoliae cortex (EEMC) limits teratoma formation of pluripotent stem cells by selective elimination of undifferentiated cells through the p53-dependent mitochondrial apoptotic pathway.
Kim A; Lee SY; Seo CS; Chung SK
Phytomedicine; 2020 Apr; 69():153198. PubMed ID: 32151917
[TBL] [Abstract][Full Text] [Related]
29. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
[TBL] [Abstract][Full Text] [Related]
31. Selection of iPSCs without mtDNA deletion for autologous cell therapy in a patient with Pearson syndrome.
Lee Y; Han J; Hwang SB; Kang SS; Son HB; Jin C; Kim JE; Lee BH; Kang E
BMB Rep; 2023 Aug; 56(8):463-468. PubMed ID: 37156631
[TBL] [Abstract][Full Text] [Related]
32. Teratomas produced from human pluripotent stem cells xenografted into immunodeficient mice - a histopathology atlas.
Damjanov I; Andrews PW
Int J Dev Biol; 2016; 60(10-11-12):337-419. PubMed ID: 28000905
[TBL] [Abstract][Full Text] [Related]
33. [Teratoma of the ovary. Clinical and pathological differences between mature and immature teratomas].
Schmidt D; Kommoss F
Pathologe; 2007 May; 28(3):203-8. PubMed ID: 17396268
[TBL] [Abstract][Full Text] [Related]
34. Generation of β Cells from iPSC of a MODY8 Patient with a Novel Mutation in the Carboxyl Ester Lipase (CEL) Gene.
Pellegrini S; Pipitone GB; Cospito A; Manenti F; Poggi G; Lombardo MT; Nano R; Martino G; Ferrari M; Carrera P; Sordi V; Piemonti L
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2322-e2333. PubMed ID: 33417713
[TBL] [Abstract][Full Text] [Related]
35. UNDIFFERENTIATED SARCOMA ARISING IN AN IMMATURE TERATOMA OF THE OVARY: A case report.
Mekni K; Mlika M; Houcine Y; ElFekih C
Int J Surg Case Rep; 2022 Dec; 101():107791. PubMed ID: 36434874
[TBL] [Abstract][Full Text] [Related]
36. Demethylation of induced pluripotent stem cells from type 1 diabetic patients enhances differentiation into functional pancreatic β cells.
Manzar GS; Kim EM; Zavazava N
J Biol Chem; 2017 Aug; 292(34):14066-14079. PubMed ID: 28360105
[TBL] [Abstract][Full Text] [Related]
37. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation.
Suzuki N; Yamazaki S; Yamaguchi T; Okabe M; Masaki H; Takaki S; Otsu M; Nakauchi H
Mol Ther; 2013 Jul; 21(7):1424-31. PubMed ID: 23670574
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic potential of mesenchymal stem cells from human iPSC-derived teratomas for osteochondral defect regeneration.
Kim J; Kim JS; Kim D; Bello AB; Kim BJ; Cha BH; Lee SH
Bioeng Transl Med; 2024 Mar; 9(2):e10629. PubMed ID: 38435815
[TBL] [Abstract][Full Text] [Related]
39. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
40. Prunellae Spica Extract Suppresses Teratoma Formation of Pluripotent Stem Cells through p53-Mediated Apoptosis.
Kim A; Lee SY; Seo CS; Chung SK
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32182802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
